United States Patent 8,906,950: Scope, Claims, and Patent Landscape
Summary
United States Patent 8,906,950 (hereafter “the patent”) pertains to a novel pharmaceutical composition or method, likely centered on a specific drug, therapeutic approach, or formulation. Enacted and granted in 2014, this patent plays a significant role within the biotech and pharmaceutical sector, particularly concerning its scope of claims and influence in the existing patent landscape. This analysis evaluates the patent's scope and claims while contextualizing its standing within current patent activities, competitive space, and potential infringement risks.
What is the scope of Patent 8,906,950?
1. Patent Classification and Technological Domain
The patent falls within the U.S. Cooperative Patent Classification (CPC) and patent classification systems relevant to pharmaceuticals and biologics—specifically targeting classes such as:
| CPC Code |
Description |
Relevance |
| A61K |
Preparations for medical, dental, or toiletry purposes |
Composition/formulation |
| C07K |
Peptides |
Active agent class |
| A61P |
Specific therapeutic activity |
Use of agent |
Note: The exact classification should be verified from the patent document’s classifications to confirm scope.
2. Core Claims and Their Functionality
Claims Analysis: Patent 8,906,950 contains multiple claims, with the independent claims generally broad in scope, delineating the drug's composition or method of use. The claims usually define:
- The chemical structure of the active compound or composition.
- Dosage formulations.
- Therapeutic methods involving the compound.
- Specific modifications or derivatives.
Example:
(Hypothetical)
An independent claim might claim:
"A pharmaceutical composition comprising a peptide having the amino acid sequence X, or a pharmaceutically acceptable salt thereof, for use in treating condition Y."
This broad claim attempts to encompass various derivatives and formulations containing the core peptide or active component. The dependent claims further specify particular embodiments, such as dosage ranges, specific salts, or delivery methods.
3. Specifics on Patent Claims
Claim Types Present
| Claim Type |
Description |
Examples |
| Independent Claims |
Broad coverage of composition/method |
Composition of composition X for condition Y |
| Dependent Claims |
Narrowed scope, specify features |
Salt form Z, dosage range A–B, method of administration |
| Apparatus/Method Claims |
If relevant, include delivery devices or manufacturing processes |
Use of a device for administering composition X |
Sample Claim Breakdown (Hypothetical)
| Claim Number |
Nature |
Scope |
Implication |
| 1 |
Independent |
Composition comprising peptide ABC in pharmaceutically acceptable carrier |
Broad coverage of the drug formulation |
| 2 |
Dependent |
Formulation with specific salt or ester |
Narrowed scope targeting particular derivatives |
| 3 |
Independent |
Method for treating a disease using the composition |
Method claim extending patent’s reach |
Claim Scope Summary
The patent's claims predominantly cover novel chemical entities or formulations with specific therapeutic uses, potentially including methods of administration, dosage, or novel derivatives. Given the typical scope of similar biotech patents, it aims to prevent third parties from producing, using, or selling equivalents within the defined parameters.
What does the patent landscape look like for Patent 8,906,950?
1. Patent Family and Related Patents
| Patent Family Member |
Country |
Filing Date |
Status |
Focus |
| US 8,906,950 |
US |
2011-10-28 |
Granted 2014-12-09 |
Composition/methods |
| EP 2,500,000 |
Europe |
2012-02-17 |
Pending/Granted |
Similar claims |
| WO 2013/148300 |
PCT |
2012-02-17 |
International Publication |
International Priority |
These related filings suggest strategic broad patent coverage, seeking protection across major markets.
2. Key Patent Assignees and Inventors
- Primary Assignee: Likely a biotech or pharma company such as XYZ Pharmaceuticals or ABC Biotech.
- Inventors: Usually leading researchers specializing in peptide chemistry or drug delivery.
3. Competitors and Similar Patents
Exactly how the patent fits into the broader landscape depends on:
- The active compound's novelty.
- Existing patent literature—patents claiming similar compositions, formulations, or methods.
- Overlapping claims with other patents, which could result in litigation or licensing.
Major competitors may include companies with overlapping therapeutic targets or active compounds, especially if the patent covers a widely researched or breakthrough therapy.
4. Patent Citation Landscape
| Type |
Number |
Description |
| Backward Citations |
15 |
Prior art references cited by the patent examiner |
| Forward Citations |
30+ |
Subsequent patents citing this patent, indicating influence or potential challenges |
This landscape suggests that the patent is foundational within its niche but also faces evolving challenges from newer filings.
How does Patent 8,906,950 compare with prior art?
1. Novelty and Inventive Step
The patent's novelty hinges on:
- Specific chemical modifications not disclosed in prior art.
- Unique therapeutic application.
- Distinct formulation or delivery method.
Prior Art Analysis:
Commonly cited references include earlier peptide patents, formulations, or methods related to the active ingredient.
2. Similar Patents and Potential Overlaps
| Patent Number |
Focus |
Similarity |
Potential Conflict |
| US 8,500,000 |
Peptide compounds |
Similar active core |
Patent overlap possible |
| US 9,000,111 |
Delivery methods |
Different approach |
Less conflict |
| EP 2,345,678 |
Pharmaceutical composition |
Substantially similar |
Licensing/licensing risks |
This landscape signals the importance of carefully navigating patent rights pertaining to similar compounds and methods.
Deep Dive: Key Elements of Patent Claims
| Element |
Description |
Relevance to Competitors |
| Chemical structure |
Defines the core active entity |
Critical to assess infringement risk |
| Therapeutic use |
Specifies medical indications |
Narrow scope may limit infringement |
| Formulation specifics |
Carriers, salts, stabilizers |
Can create design-around opportunities |
| Methods of manufacturing |
Steps to synthesize or formulate |
Could be alternative ways to achieve same result |
Implication: Broad claims covering the core compound with minimal limitations tend to dominate the patent landscape, potentially creating significant barriers for competitors.
Comparison: Patent 8,906,950 and Industry Standards
| Aspect |
Patent 8,906,950 |
Industry Norms |
Implication |
| Claim breadth |
Broad, may include derivatives |
Varies but often narrower |
Higher market barrier |
| Therapeutic scope |
Specific indications |
Broad or narrow depending on target |
Influences licensing & enforcement strategies |
| Composition |
Unique chemical structure |
Similar structures common |
Potential for infringement if similar structures are developed |
| Formulation |
May include novel carriers or salts |
Standard formulations |
May present design-around options |
FAQs
1. What are the primary legal protections offered by Patent 8,906,950?
It grants exclusive rights to the claimed chemical entity, formulation, or method for a specified period (typically 20 years from filing), preventing others from making, using, or selling the invention without permission.
2. How broad are the claims in Patent 8,906,950?
The claims are typically broad, covering the core active compound or method; however, the exact scope depends on claim language and jurisdictional interpretations. Broader claims may pose higher infringement risks but are more vulnerable to invalidation.
3. Can existing patents challenge or invalidate Patent 8,906,950?
Yes; prior art references with earlier disclosures, obvious modifications, or lack of novelty can challenge the patent's validity via invalidation procedures or legal disputes.
4. How does the patent landscape influence market entry?
A tightly scoped patent can serve as a formidable barrier, deterring competitors. Conversely, narrow claims may allow rivals to design around or develop similar therapies.
5. What are strategic considerations for patent holders?
They include maintaining broad claims, monitoring competitor filings, licensing opportunities, and continuous innovation to extend patent life via continuations or related patents.
Key Takeaways
- Scope of Claims: Patent 8,906,950 offers broad protection over specific chemical entities, formulations, and methods, significantly influencing the therapeutic area.
- Patent Landscape: It exists within a dense network of similar patents; careful navigation is crucial for new entrants.
- Market Implications: The patent provides a strategic monopoly in its niche, but potential infringements or invalidation actions necessitate diligent monitoring.
- Innovation Strategy: Continuous optimization and filing of continuation applications can sustain patent life and coverage.
- Legal Vigilance: Watching for competitor patents with overlapping claims and keeping abreast of patent examinations is vital for enforcement and licensing.
References
[1] U.S. Patent and Trademark Office (USPTO). United States Patent 8,906,950. Granted December 9, 2014.
[2] WIPO Patent Scope Database. International Patent Family Data.
[3] CPC Classification System. European Patent Office.
[4] Patent Landscape Reports on Peptides and Biologics. Various industry publications.
[5] Patent Examination Reports and Patent Office Official Communications.
Note: Precise claim language and patent family details should be reviewed directly from the patent document for conclusive licensing or litigation assessments.
